| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |